ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH
SAN DIEGO, October 28, 2015 /PRNewswire/ – ProSciento Inc., a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a collaboration of experts in biomarker discovery and […]
ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year
SAN DIEGO, October 13, 2015 – ProSciento Inc., a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, celebrates its 11th year as a corporate sponsor of San Diego’s […]
ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development
SAN DIEGO, October 8, 2015 /PRNewswire/ – ProSciento Inc., a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today the launch of its white paper series focused […]
ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting
SAN DIEGO, September 10, 2015 – ProSciento Inc., an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, and sponsors will present prominent study results at next week’s European […]
ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership
Two renowned metabolic clinical research companies – one focused on preclinical research and discovery, the other on translational clinical research – join forces to validate novel compounds for NASH, diabetes and obesity […]
ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston
SAN DIEGO, May 29, 2015 – ProSciento Inc., an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, will present study results at next week’s American Diabetes Association (ADA) […]
ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt
SAN DIEGO, May 7, 2015 /PRNewswire/ – ProSciento, Inc., an early engagement clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today the appointment of Dr. Michael Trautmann as Senior […]
ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego
SAN DIEGO, April 15, 2015 – ProSciento, Inc., an early engagement clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today its 11th year as a corporate sponsor […]
New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods
With contributions from world-renowned experts in metabolism, the textbook is the first to extensively analyze and illustrate techniques for use in early phase clinical studies of new drugs for diabetes, obesity […]